Prostatic Neoplasms

specific

A benign, borderline, or malignant neoplasm that affects the prostate gland. Representative examples include benign prostate phyllodes tumor, prostatic intraepithelial neoplasia, prostate carcinoma, and prostate sarcoma.

67

Centers

169

Active Trials

Cancer Funding

Top Centers for Prostatic Neoplasms(67)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
79.3
2
NCI Comprehensive
High-Volume Research Center
78.7
3
NCI Comprehensive
High-Volume Research Center
76.3
4
BC CancerVancouver, BC
High-Volume Research Center
74.2
574.1
6
NCI Clinical
High-Volume Research Center
73.0
7
NCI Comprehensive
High-Volume Research Center
72.6
8
NCI Comprehensive
High-Volume Research Center
70.4
9
NCI Comprehensive
Active Research Program
66.8
10
NCI Clinical
Active Research Program
65.9
11
NCI Comprehensive
Active Research Program
65.7
12
Active Research Program
65.7
13
Active Research Program
65.3
14
Active Research Program
63.4
15
NCI Comprehensive
Active Research Program
63.1
16
Active Research Program
62.4
17
NCI Comprehensive
Active Research Program
62.1
18
Active Research Program
61.5
19
Active Research Program
60.1
2059.4
21
NCI Comprehensive
Active Research Program
59.2
22
Active Research Program
58.9
23
Active Research Program
58.2
24
Active Research Program
57.6
25
NCI Comprehensive
Active Research Program
55.5
26
NCI Comprehensive
Active Research Program
54.6
27
NCI Comprehensive
Active Research Program
54.0
28
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
53.7
29
NCI Comprehensive
Active Research Program
53.2
30
Active Research Program
52.7
31
Active Research Program
52.2
32
NCI Comprehensive
Active Research Program
51.3
33
NCI Comprehensive
Active Research Program
51.3
34
NCI Comprehensive
Active Research Program
50.9
35
NCI Clinical
Active Research Program
50.6
36
NCI Comprehensive
Active Research Program
50.3
37
NCI Comprehensive
Active Research Program
50.0
38
NCI Comprehensive
Active Research Program
48.8
39
NCI Comprehensive
Active Research Program
46.4
40
NCI Comprehensive
Active Research Program
46.1
41
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
45.8
42
NCI Comprehensive
Active Research Program
45.5
4344.6
44
Active Research Program
44.6
45
NCI Comprehensive
Active Research Program
43.1
46
NCI Comprehensive
Active Research Program
42.5
47
NCI Comprehensive
Active Research Program
41.3
48
NCI Clinical
Active Research Program
40.1
49
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
39.8
50
NCI Comprehensive
Active Research Program
38.6
51
NCI Comprehensive
Active Research Program
38.0
52
Active Research Program
37.4
53
Active Research Program
37.1
54
GW Cancer CenterWashington, DC
Active Research Program
36.8
55
NCI Comprehensive
Active Research Program
36.5
56
NCI Clinical
Active Research Program
35.9
57
Contributing Research Center
34.9
58
Contributing Research Center
34.9
59
Contributing Research Center
34.9
60
NCI Comprehensive
Contributing Research Center
34.1
61
NCI Comprehensive
Contributing Research Center
32.6
62
NCI Comprehensive
Contributing Research Center
30.2
63
NCI Comprehensive
Contributing Research Center
29.9
64
NCI Clinical
Contributing Research Center
28.4
65
NCI Comprehensive
Contributing Research Center
28.1
66
NCI Comprehensive
Contributing Research Center
25.1
6723.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →